The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Management of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome: A Systematic Review and Network Meta-analysis
Abstract
CONTEXT: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is common, but trial evidence is conflicting and therapeutic options are controversial. OBJECTIVE: To conduct a systematic review and network meta-analysis comparing mean symptom scores and treatment response among α-blockers, antibiotics, anti-inflammatory drugs, other active drugs (phytotherapy, glycosaminoglycans, finasteride, and neuromodulators), and placebo. DATA SOURCES: We searched MEDLINE from 1949 and EMBASE from 1974 to November 16, 2010, using the PubMed and Ovid search engines. STUDY SELECTION: Randomized controlled trials comparing drug treatments in CP/CPPS patients. DATA EXTRACTION: Two reviewers independently extracted mean symptom scores, quality-of-life measures, and response to treatment between treatment groups. Standardized mean difference and random-effects methods were applied for pooling continuous and dichotomous outcomes, respectively. A longitudinal mixed regression model was used for network meta-analysis to indirectly compare treatment effects. DATA SYNTHESIS: Twenty-three of 262 studies identified were eligible. Compared with placebo, α-blockers were associated with significant improvement in symptoms with standardized mean differences in total symptom, pain, voiding, and quality-of-life scores of -1.7 (95% confidence interval [CI], -2.8 to -0.6), -1.1 (95% CI, -1.8 to -0.3), -1.4 (95% CI, -2.3 to -0.5), and -1.0 (95% CI, -1.8 to -0.2), respectively. Patients receiving α-blockers or anti-inflammatory medications had a higher chance of favorable response compared with placebo, with pooled RRs of 1.6 (95% CI, 1.1-2.3) and 1.8 (95% CI, 1.2-2.6), respectively. Contour-enhanced funnel plots suggested the presence of publication bias for smaller studies of α-blocker therapies. The network meta-analysis suggested benefits of antibiotics in decreasing total symptom scores (-9.8; 95% CI, -15.1 to -4.6), pain scores (-4.4; 95% CI, -7.0 to -1.9), voiding scores (-2.8; 95% CI, -4.1 to -1.6), and quality-of-life scores (-1.9; 95% CI, -3.6 to -0.2) compared with placebo. Combining α-blockers and antibiotics yielded the greatest benefits compared with placebo, with corresponding decreases of -13.8 (95% CI, -17.5 to -10.2) for total symptom scores, -5.7 (95% CI, -7.8 to -3.6) for pain scores, -3.7 (95% CI, -5.2 to -2.1) for voiding, and -2.8 (95% CI, -4.7 to -0.9) for quality-of-life scores. CONCLUSIONS: α-Blockers, antibiotics, and combinations of these therapies appear to achieve the greatest improvement in clinical symptom scores compared with placebo. Anti-inflammatory therapies have a lesser but measurable benefit on selected outcomes. However, beneficial effects of α-blockers may be overestimated because of publication bias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conclusions from two recent meta‐analyses were mixed; one reported that NSAIDs were 80% more likely to achieve a favourable response than placebo (n = 190, relative risk [RR]: 1.8, 95% CI 1.2–2.6), based on the combination of three trials evaluating rofecoxib, celecoxib and a corticosteroid 63. The second analysis, based on only the rofecoxib and celecoxib trials, concluded that no significant”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [63]
In the citing paper
“Recent direct meta‐analyses of these trials showed that antibiotics provide symptom improvement, but not at a significant level 63, 64”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [63]
In the citing paper
“A recent systematic review and network meta‐analysis of α‐blocker RCTs found significant differences vs placebo in total, pain, voiding and QoL NIH‐CPSI scores 63.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · cited 1×
“) independently assessed risk of bias of each study using an established tool.(17) Six domains were assessed: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other sources of bias.”
MethodCombination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
Simultaneous comparison of multiple treatments: Combining direct and indirect evidence.
Caldwell, D. M., Ades, A. E., & Higgins, J. P. T. (2005) · BMJ · doi:10.1136/bmj.331.7521.897 · Cited by 1,600
NIH Consensus Definition and Classification of Prostatitis
Krieger, J. N., Nyberg, Jr., & Nickel, J. C. (1999) · JAMA · doi:10.1001/jama.282.3.236 · Cited by 1,473
LITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
HOW COMMON IS PROSTATITIS? A NATIONAL SURVEY OF PHYSICIAN VISITS
COLLINS, M. M., STAFFORD, R. S., O'LEARY, M. P., & BARRY, M. J. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63564-x · Cited by 658
Shoskes, D. A., Zeitlin, S. I., Shahed, A., & Rajfer, J. (1999) · Urology · doi:10.1016/s0090-4295(99)00358-1 · Cited by 408
Roberts, R. O., Lieber, M. M., Rhodes, T., Girman, C. J., Bostwick, D. G., & Jacobsen, S. J. (1998) · Urology · doi:10.1016/s0090-4295(98)00034-x · Cited by 294
the Chronic Prostatitis Collaborative Research Network, McNaughton Collins, M., Pontari, M. A., O’Leary, M. P., Calhoun, E. A., Santanna, J., Landis, J. R., Kusek, J. W., & Litwin, M. S. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.01223.x · Cited by 281
Alexander, R. B., Propert, K. J., Schaeffer, A. J., Landis, J. R., Nickel, J. C., O'Leary, M. P., Pontari, M. A., McNaughton-Collins, M., Shoskes, D. A., Comiter, C. V., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-8-200410190-00005 · Cited by 262
Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis”
Krieger, J. N., Egan, K. J., Ross, S. O., Jacobs, R., & Berger, R. E. (1996) · Urology · doi:10.1016/s0090-4295(96)00421-9 · Cited by 221
Nickel, J. C., Downey, J., Clark, J. M., Casey, R. W., Pommerville, P. J., Barkin, J., Steinhoff, G., Brock, G. B., Patrick, A., Flax, S., et al. (2003) · Urology · doi:10.1016/s0090-4295(03)00583-1 · Cited by 206
Shoskes, D. A., Nickel, J. C., Dolinga, R., & Prots, D. (2009) · Urology · doi:10.1016/j.urology.2008.09.074 · Cited by 196
Song, F., Harvey, I., & Lilford, R. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.06.006 · Cited by 195
Diagnosis and treatment of 409 patients with prostatitis syndromes
De La Rosette, J. J. M. C. H., Hubregtse, M. R., Meuleman, E. J. H., Stolk-engelaar, M. V. M., & Debruyne, F. M. J. (1993) · Urology · doi:10.1016/0090-4295(93)90584-w · Cited by 193
Shoskes, D. A., Nickel, J. C., & Kattan, M. W. (2010) · Urology · doi:10.1016/j.urology.2010.01.021 · Cited by 193
Alfuzosin and Symptoms of Chronic Prostatitis–Chronic Pelvic Pain Syndrome
Nickel, J. C., Krieger, J. N., McNaughton-Collins, M., Anderson, R. U., Pontari, M., Shoskes, D. A., Litwin, M. S., Alexander, R. B., White, P. C., Berger, R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803240 · Cited by 188
Wagenlehner, F. M. E., Schneider, H., Ludwig, M., Schnitker, J., Brähler, E., & Weidner, W. (2009) · European Urology · doi:10.1016/j.eururo.2009.05.046 · Cited by 186
Diagnosis and Treatment of Chronic Abacterial Prostatitis
COLLINS, M. M., MacDonald, R., & Wilt, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00013 · Cited by 167
Cheah, P. Y., Liong, M. L., Yuen, K. H., Teh, C. L., Khor, T., Yang, J. R., Yap, H. W., & Krieger, J. N. (2003) · PubMed · doi:10.1097/01.ju.0000042927.45683.6c · Cited by 145
HOCHREITER, W. W., Nadler, R. B., Koch, A. E., Campbell, P. L., Ludwig, M., Weidner, W., & Schaeffer, A. J. (2000) · Urology · doi:10.1016/s0090-4295(00)00844-x · Cited by 127
KAPLAN, S. A., VOLPE, M. A., & TE, A. E. (2004) · Journal of Urology · doi:10.1097/01.ju.0000101487.83730.80 · Cited by 106
THE NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX
Litwin, M. S., McNaughton‐Collins, M., Fowler, F. J., Nickel, J. C., Calhoun, E. A., Pontari, M. A., Alexander, R. B., Farrar, J. T., & O’Leary, M. P. (1999) · The Journal of Urology · doi:10.1097/00005392-199908000-00022 · Cited by 94
Musculoskeletal Dysfunction in Men With Chronic Pelvic Pain Syndrome Type III: A Case-control Study
HETRICK, D. C., CIOL, M. A., ROTHMAN, I., TURNER, J. A., FREST, M., & BERGER, R. E. (2003) · Journal of Urology · doi:10.1097/01.ju.0000080513.13968.56 · Cited by 94
Pontari, M. A., Krieger, J. N., Litwin, M. S., White, P. C., Anderson, R. U., McNaughton-Collins, M., Nickel, J. C., Shoskes, D. A., Alexander, R. B., O'Leary, M., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.319 · Cited by 81
Chronic bacterial prostatitis: An evolving clinical enigma
Nickel, J. C., & Moon, T. (2005) · Urology · doi:10.1016/j.urology.2004.12.028 · Cited by 70
Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)
Zhao, W. P., Zhang, Z. G., Li, X. D., Yu, D., Rui, X. F., Li, G. H., & Ding, G. Q. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009005000021 · Cited by 56
Galley, H. F., Nelson, S. J., Dubbels, A. M., & Webster, N. R. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00029 · Cited by 52
Yang, G., Wei, Q., Li, H., Yang, Y., Zhang, S., & Dong, Q. G. (2006) · Journal of Andrology · doi:10.2164/jandrol.106.000661 · Cited by 40
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma
Li, T., Lindsley, K., Rouse, B., Hong, H., Shi, Q., Friedman, D. S., Wormald, R., & Dickersin, K. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.09.005 · Cited by 320
Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Magistro, G., Wagenlehner, F. M. E., Grabe, M., Weidner, W., Stief, C. G., & Nickel, J. C. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.061 · Cited by 294
Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials
Trinquart, L., Attiche, N., Bafeta, A., Porcher, R., & Ravaud, P. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2521 · Cited by 202
Physiotherapy management of patients with chronic pelvic pain (CPP): a systematic review
Klotz, S. G. R., Schön, M., Ketels, G., Löwe, B., & Brünahl, C. A. (2019) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2018.1455251 · Cited by 66
“Several non-surgical as well as surgical strategies exist (Anothaisintawee et al., 2011; Yunker et al., 2012).”
Background
Metadata
- Authors
- Anothaisintawee, T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-01-05
- Volume
- 305
- Issue
- 1
- Pages
- 78
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2080628209
- Cited by
- 278
- References
- 31
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.